Healthy Extracts (HYEX) Other financing activities (2015 - 2025)
Healthy Extracts (HYEX) posted quarterly Other financing activities of -$64838.0 for Q4 2025, down 259.53% quarter-over-quarter from $40643.0 in Q3 2025.
Healthy Extracts (HYEX) Other financing activities (2015 - 2025) Analysis & Trends
Healthy Extracts' Other financing activities history runs 5 years deep, the most recent figure standing at -$64838.0 for Q4 2025.
- In Q4 2025, Other financing activities changed N/A year-over-year to -$64838.0; the TTM figure through Dec 2025 stood at -$24195.0 (changed N/A YoY), while the FY2025 annual figure was -$58364.0, changed N/A from the prior year.
- Other financing activities for Q4 2025 stood at -$64838.0, down from $40643.0 in the prior quarter.
- The five-year high for Other financing activities was $40643.0 in Q3 2025, with the low at -$64838.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Healthy Extracts | 19.90 Mn | 19.71 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -64,838.00 |
| Dec 31, 2025 | -64,838.00 |
| Sep 30, 2025 | 40,643.00 |
| Sep 30, 2025 | 40,643.00 |
| Mar 31, 2022 | -16,890.00 |
| Mar 31, 2022 | -16,890.00 |
| Mar 31, 2018 | -1,500.00 |
| Mar 31, 2018 | -1,500.00 |
| Jun 30, 2016 | 32,500.00 |
| Jun 30, 2016 | 32,500.00 |
| Mar 31, 2016 | 5,000.00 |
| Mar 31, 2016 | 5,000.00 |
| Dec 31, 2015 | 25,000.00 |
| Dec 31, 2015 | 25,000.00 |